amlodipine besylate and benazepril hydrochloride
Generic: amlodipine besylate and benazepril hydrochloride
Labeler: remedyrepack inc.Drug Facts
Product Profile
Brand Name
amlodipine besylate and benazepril hydrochloride
Generic Name
amlodipine besylate and benazepril hydrochloride
Labeler
remedyrepack inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
amlodipine besylate 5 mg/1, benazepril hydrochloride 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
70518-4386
Product ID
70518-4386_3955ccba-7a60-dca6-e063-6294a90ac88d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA078466
Listing Expiration
2026-12-31
Marketing Start
2025-07-06
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
705184386
Hyphenated Format
70518-4386
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
amlodipine besylate and benazepril hydrochloride (source: ndc)
Generic Name
amlodipine besylate and benazepril hydrochloride (source: ndc)
Application Number
ANDA078466 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
- 20 mg/1
Packaging
- 90 CAPSULE in 1 BOTTLE, PLASTIC (70518-4386-0)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3955ccba-7a60-dca6-e063-6294a90ac88d", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898356"], "spl_set_id": ["dc206611-5188-40a6-b025-61db41f68a5a"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE, PLASTIC (70518-4386-0)", "package_ndc": "70518-4386-0", "marketing_start_date": "20250706"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "70518-4386_3955ccba-7a60-dca6-e063-6294a90ac88d", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "70518-4386", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA078466", "marketing_category": "ANDA", "marketing_start_date": "20250706", "listing_expiration_date": "20261231"}